AM22-08-O - AM22-08-O: (On-Demand) Plenary Abstract Session (Enduring)

Learning Objectives:

• Understand the impact of pathogen reduction on platelet transfusion safety.
• Evaluate the risk of transfusion-transmitted SARS-CoV-2.
• Examine the mechanism of alloantibody production after platelet transfusions.
• Investigate the use of platelets as a method deliver therapeutic proteins.
• Understand the mechanism underlying the Helgeson phenotype, the serological null phenotype of the Knops blood group system.

Speaker(s):

• Adèle Couvidou, EFS GRAND EST
• Rachael Jackman, PhD, Vitalant Research Institute
• Scott Koepsell, MD PhD, University of Nebraska Medical Center
• Jerry Leung, Biochemistry and Molecular Biology, The University of British Columbia
• John Pitman, Scientific and Medical Affairs, Cerus Corporation
• Ping Chun Wu, MSc, Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University

Moderator(s):

• Melissa M. Cushing, MD, New York-Presbyterian Hospital-Weill Cornell Medicine